We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
(+5.4%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$3.68M |
| 2 |
Red Robin
RRGB
|
+$3.46M |
| 3 |
Intapp
INTA
|
+$3.34M |
| 4 |
O-I Glass
OI
|
+$3.16M |
| 5 |
PDF Solutions
PDFS
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$4.8M |
| 2 |
Target Hospitality
TH
|
+$4.6M |
| 3 |
PDS Biotechnology
PDSB
|
+$4.36M |
| 4 |
Digi International
DGII
|
+$4.3M |
| 5 |
KLX Energy Services
KLXE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25% |
| 2 | Technology | 21.39% |
| 3 | Industrials | 20.38% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
RLI Corp
RLI
$5.89B
| $1.06M | 0.21% |
16,008
-4,518
| -22% | -$300K |
|
|
DO
227
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.06M | 0.21% |
+88,077
| New | +$1.01M |
|
228
LiveOne
LVO
$58.2M
| $1.06M | 0.21% |
+92,959
| New | +$883K |
|
229
Teekay Tankers
TNK
$2.68B
| $1.06M | 0.21% |
24,684
-29,479
| -54% | -$1.09M |
|
|
WIRE
230
DELISTED
Encore Wire Corp
WIRE
| $1.03M | 0.2% |
+5,573
| New | +$950K |
|
231
Pacific Biosciences
PACB
$370M
| $993K | 0.2% |
+85,761
| New | +$853K |
|
|
ATXS
232
DELISTED
Astria Therapeutics
ATXS
| $959K | 0.19% |
72,129
-19,216
| -21% | -$260K |
|
233
Voyager Therapeutics
VYGR
$201M
| $955K | 0.19% |
+123,818
| New | +$985K |
|
|
QIPT
234
DELISTED
Quipt Home Medical
QIPT
| $940K | 0.18% |
+134,059
| New | +$826K |
|
235
Nextpower Inc
NXT
$15.7B
| $929K | 0.18% |
+25,630
| New | +$811K |
|
236
Aurinia Pharmaceuticals
AUPH
$2.11B
| $904K | 0.18% |
+82,453
| New | +$726K |
|
237
Scorpio Tankers
STNG
$3.81B
| $847K | 0.17% |
15,046
-37,875
| -72% | -$2.07M |
|
238
Taylor Devices
TAYD
$175M
| $771K | 0.15% |
+38,462
| New | +$612K |
|
|
NUVL
239
DELISTED
Nuvalent
NUVL
| $724K | 0.14% |
27,754
| – | – |
|
240
NWPX Infrastructure Inc
NWPX
$1.15B
| $479K | 0.09% |
15,352
-25,383
| -62% | -$916K |
|
241
Pangaea Logistics
PANL
$485M
| $453K | 0.09% |
+77,144
| New | +$463K |
|
242
ARS Pharmaceuticals
SPRY
$612M
| $409K | 0.08% |
62,798
-61,975
| -50% | -$476K |
|
|
NPKI
243
NPK International
NPKI
$1.14B
| $330K | 0.06% |
+85,731
| New | +$375K |
|
244
Direct Digital Holdings
DRCT
$1.91M
| $245K | 0.05% |
+344
| New | +$318K |
|
245
Acadia Healthcare
ACHC
$2.94B
| – | – |
-20,376
| Closed | -$1.68M |
|
246
ADT
ADT
$5.58B
| – | – |
-184,960
| Closed | -$1.68M |
|
247
Addus HomeCare
ADUS
$2.23B
| – | – |
-10,776
| Closed | -$1.07M |
|
248
American Eagle Outfitters
AEO
$3.01B
| – | – |
-153,654
| Closed | -$2.15M |
|
249
Albany International
AIN
$1.78B
| – | – |
-11,787
| Closed | -$1.16M |
|
250
Amalgamated Financial
AMAL
$1.49B
| – | – |
-37,471
| Closed | -$863K |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.
- EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
- EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
- EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
- EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
- EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
- EAM Investors opened 139 new positions and closed 144 in Q1 2023.
- EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.
Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.